Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.

This study suggests that the U11-DOX/CUR NPs have promising potential for combination treatment of lung cancer.
PMID: 30798129 [PubMed - as supplied by publisher]

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 21, 2019 Category: Drugs & Pharmacology Authors: Hong Y, Che S, Hui B, Yang Y, Wang X, Zhang X, Qiang Y, Ma H Tags: Biomed Pharmacother Source Type: research